Fishawack Health Founder's Deep History in Healthcare Communications Blends Nicely with Global Scientific Communications Agency's Upcoming Buy-and-Build Strategy

Fishawack Health Founder's Deep History in Healthcare Communications Blends Nicely With Global Scientific Communications Agency's Upcoming Buy-and-Build Strategy

Insights into the Skin Microbiome-Metabolome Nexus Revolutionize Eczema Management Strategies

Research Organizations Can Now Securely Co-Create and Share Curated Reference Repositories in Real Time

Spin-out unites three sites to create a leading global CDMO as further significant investments announced at Holmes Chapel site

This additional funding comes at the heels of Selux announcing their third FDA 510(k) clearance on their direct from Positive Blood Culture Separator, making them the only single-platform technology capable of delivering rapid AST results for both positive blood culture and isolated colonies.

Innovative pro-drug delivers superior efficacy with improved drug-like properties and safety profile

Long-standing reputation for robust quality is confirmed as company enters 2024

Phase 1a study of first hormone-free male pill completes enrollment

Limulus Amebocyte Lysate (LAL) Can Now Be Produced Without Harvesting the Blood of ~800,000 Horseshoe Crabs Each Year, Which Will Help Restore Their Natural Population

Government and industry have tried and failed to stem the overdose epidemic for more than two decades. Open-source PillSafe Technologies offer hope.

DropSafe® Sicura™ is the first and only fully passive safety needle in North America. Sicura™ is designed to eliminate needlestick injuries, providing a safe injection experience, and is distributed by HTL-Strefa Inc., an MTD company.

SingleTimeMicroneedles wins the Food, Nutrition, and Health Category.

New Location Positions CIL for Product Development and Future Growth

Former Whitehouse Analytical Laboratory is Now Part of the Pace® Laboratory Network

Google Cloud’s Powerful AI Models for Healthcare and Life Sciences Research Now Available as Point-and-Click Workflows via Form Bio's Bioinformatics Platform, Available on Google Cloud Marketplace

Baltimore-based biotechnology leader, Elixirgen Scientific, Inc., achieves ISO 9001:2015 Quality Management System certification, strengthening commitment to quality, excellence in biotechnology and drug discovery.

Combined Solution Set Addresses Critical Hurdles in Bringing Gene Therapy Products to IND

FIECON, a leading health economics consultancy, in collaboration with Nested Knowledge, a leading provider of AI-based SaaS platform solutions, has embarked on a transformative journey together. By harnessing innovative AI technology, this collaboration aims to significantly streamline the Systematic Literature Review (SLR) and meta-analysis process.

The Selux PBC Separator, part of the Next Generation Phenotyping (NGP) System, makes this the only FDA cleared, single-platform technology capable of delivering rapid AST results for both positive blood culture and isolated colonies.

A Scientific Personalized Approach Poised to Revolutionize How People Combat Hair Loss

Two Global Leaders in Site Enablement Technology Respond to Research Site Demand for End-to-End Solutions to Increase Efficiencies Across All Trials

Hyris’ molecular diagnostic technology has been adapted to enable real-time surveillance of mosquito vector insecticide resistance, which will aid in malaria control campaigns.

News of the Successful Trial Comes Amid an Oversubscribed Investor Round and Preparation for Series A Financing Round

Leading diagnostics laboratory Genesis Reference Laboratories, which recently celebrated five years in the industry, is excited to announce it has recently upgraded every testing menu. The upgrades will provide more individualized testing, which allows Genesis Reference Laboratories to offer some of the most competitive menus in the industry while allowing clients to practice responsible use of healthcare dollars.

Empowering Our Clients With Advanced Solutions

Researchers at the BioMed X Institute and the Universitätsmedizin Mannheim just published the results of their collaboration around a new neoepitope vaccine in diffuse midline glioma in Science Advances.